Skip to content

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

News

Select Year
Clinical Trials
Search …

November 1, 2010

Oncolytics Biotech(R) Inc. Collaborators to Present Reovirus Research at the EORTC-NCI-AACR Meeting

October 26, 2010

Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the International Symposium on CTL and Immunostimulation

October 4, 2010

MEDIA ADVISORY – Oncolytics Biotech(R) Inc. to Present at BIO Investor Forum

September 28, 2010

Oncolytics Biotech Inc. Announces Issuance of Key U.S. Patent

September 27, 2010

Media Advisory – Oncolytics Biotech(R) Inc. to Present at JMP Securities Healthcare Conference

September 9, 2010

Media Advisory – Oncolytics Biotech(R) Inc. to Present at Rodman & Renshaw Annual Global Investment Conference

September 2, 2010

Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute

August 5, 2010

Media Advisory – Oncolytics Biotech(R) Inc. to Present at 30th Annual Canaccord Genuity Growth Conference

July 29, 2010

Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results

July 19, 2010

Oncolytics Biotech(R) Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN(R) in Head and Neck Cancers

Page 54 of 71

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

Our Mission
Leadership
Board of Directors
Careers
Contact

Science

Our Science
Pipeline
Resources

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Manage Consent

Copyright © 2026 Oncolytics Biotech Inc.